3YJ-27065-83368
2 vaccinations
8 coded responses
16 check-ins
8 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 074 / NJ
- Registered
- 2021-03-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-24
Dose 1 — Pfizer-BioNTech
-
2021-03-31
Registered in v-safe
- 2021-04-02
- 2021-04-07
-
2021-04-13
Dose 2 — Pfizer-BioNTech
- 2021-04-13
-
2021-04-14
Survey response — days 1–6 daily, dose 2MedDRA: Multiple sclerosis, Pre-existing disease — Feeling: Good · Site: PainFree text: Slight increase in usual MS symptoms, not as bad as with first shot.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-15
Survey response — days 1–6 daily, dose 2MedDRA: Condition aggravated, Pre-existing disease, Pyrexia — Feeling: Fair · Fever · Headache, Joint pains, Fatigue or tiredness, NauseaFree text: Everyday MS symptoms worse, probably from low grade feverMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-16
Survey response — days 1–6 daily, dose 2MedDRA: Pre-existing disease, Pyrexia — Feeling: Fair · FeverFree text: Every day MS symptoms worse, probably from low grade fever.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-17
Survey response — days 1–6 daily, dose 2MedDRA: Muscular weakness — Feeling: Fair · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Feel like Im having an MS relapse - weakness in arms and legs.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-20
- 2021-04-27
- 2021-05-04
-
2021-05-11
Survey response — day 28, dose 2MedDRA: Migraine, Pre-existing disease — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: I seem to be having more migraines for the last few weeks, rarely had them since menopause in my late forties.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-18
Survey response — day 35, dose 2MedDRA: Headache, Hypertension — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Headaches, blood pressure has been higher. Dont know if its related, but reporting it.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-27
- 2021-07-13
-
2021-10-12
Survey response — 6 months, dose 2MedDRA: Psoriasis, Skin disorder — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Skin issues, psoriasis most likely on hands and bottom of feet, came on suddenly and have had for quite a few weeks now.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-13
Survey response — 12 months, dose 2MedDRA: Skin disorder — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Unknown skin conditions on hands and feet, waiting for diagnosis.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-24 | Pfizer-BioNTech | |
| 2 | 2021-04-13 | Pfizer-BioNTech |
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Slight increase in usual MS symptoms, not as bad as with first shot.
Systemic reaction (other): Everyday MS symptoms worse, probably from low grade fever
Systemic reaction (other): Every day MS symptoms worse, probably from low grade fever.
Systemic reaction (other): Feel like Im having an MS relapse - weakness in arms and legs.
Release 8 — day 28, dose 2
Symptoms: I seem to be having more migraines for the last few weeks, rarely had them since menopause in my late forties.
Release 8 — day 35, dose 2
Symptoms: Headaches, blood pressure has been higher. Dont know if its related, but reporting it.
Release 10 — 6 months, dose 2
Symptoms: Skin issues, psoriasis most likely on hands and bottom of feet, came on suddenly and have had for quite a few weeks now.
Release 11 — 12 months, dose 2
Symptoms: Unknown skin conditions on hands and feet, waiting for diagnosis.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Hypertension | ✓ | ✓ | ✓ |
| SD | Migraine | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Psoriasis | · | · | ✓ |
| SD | Skin disorder | · | · | ✓ |
| SRO | Condition aggravated | ✓ | ✓ | ✓ |
| SRO | Multiple sclerosis | ✓ | ✓ | ✓ |
| SRO | Muscular weakness | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Pyrexia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release